文献速递关节外科

乳腺癌病史增加全髋关节置换术后90天肺栓塞发生率与报销费用:一项全国配对分析

History of Breast Cancer Increases 90-Day Pulmonary Embolism Rates and Reimbursements After Total Hip Arthroplasty: A National Matched-Pair Analysis.
PubMed 文献 · J Arthroplasty · 2017-10-31

本研究基于全美Medicare记录开展回顾性病例对照研究,按年龄和性别1:1匹配,比较有乳腺癌病史患者与无该病史患者全髋关节置换术后90天结局。结果显示,有乳腺癌病史组肺栓塞发生率、胸部CT使用率及平均90天报销费用均高于对照组,其他内科和外科并发症在两组间分布均等。作者认为外科医生应意识到肺栓塞风险增加,并对这类患者采用更积极的血栓预防方案。

要点

  • 有乳腺癌病史者全髋关节置换术后90天肺栓塞发生率为0.59%,高于无该病史者的0.45%(P = .003)。
  • 有乳腺癌病史者胸部CT使用率为1.72%,高于无该病史者的1.18%(P < .001)。
  • 有乳腺癌病史者平均90天报销费用为15,432美元,高于无该病史者的14,701美元(P = .011)。

核心结论

  • 有乳腺癌病史的患者在全髋关节置换术后90天内肺栓塞发生率、胸部CT使用率和平均90天报销费用均高于无该病史的匹配对照。
  • 作者认为外科医生应意识到这类患者肺栓塞风险增加,并采用更积极的血栓预防方案。

研究设计与样本

  • 本研究为基于全美Medicare记录的回顾性病例对照研究,按年龄和性别进行1:1匹配以降低混杂。
  • 研究终点包括住院时长、内科并发症、外科并发症和费用(以报销费用衡量)。

主要发现

  • 有乳腺癌病史组肺栓塞发生率为0.59%,无该病史组为0.45%(P = .003)。
  • 有乳腺癌病史组胸部CT使用率为1.72%,无该病史组为1.18%(P < .001)。
  • 有乳腺癌病史组平均90天报销费用为15,432美元,无该病史组为14,701美元(P = .011)。
  • 其他内科和外科并发症在两组队列中分布均等。

临床怎么用

  • 作者认为外科医生应意识到有乳腺癌病史患者全髋关节置换术后肺栓塞风险增加,并采用更积极的血栓预防方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Rates of total hip arthroplasty (THA) are projected to increase in the coming decades. Multiple studies have focused on identifying risk factors for adverse events after joint arthroplasty, and recent attention has been directed toward cancer. Very limited data have been published examining the effects of history of malignancy on outcomes after THA. With a concomitant increase in breast cancer diagnosis and treatments in recent years, it is expected that orthopedic surgeons will likely see more breast cancer survivors in clinic. The purpose of this study is to examine the effects of a personal history of breast cancer on 90-day outcomes after THA. METHODS: We conducted a retrospective case-control study of the entire Medicare records. The endpoints of this study included length of stay, medical complications, surgical complications, and costs (examined here as reimbursements). Patients were matched by age and gender in order to decrease confounding. A 1:1 matching was performed. RESULTS: After age and demographics matching, our findings demonstrated that patients with a history of breast cancer have increased rates of pulmonary embolism (0.59% vs 0.45%, P = .003), increased use of chest computed tomography (1.72% vs 1.18%, P < .001), and higher mean 90-day reimbursements (mean $15,432 vs mean $14,701, P = .011) in the 90 days following surgery. Other medical and surgical complications were equally distributed in both cohorts. CONCLUSION: Surgeons should be aware of the increased rate of pulmonary embolism and have a more aggressive thromboprophylaxis protocol in these patients.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Rosas S, Marquez-Lara A, Bracey DN, et al. History of Breast Cancer Increases 90-Day Pulmonary Embolism Rates and Reimbursements After Total Hip Arthroplasty: A National Matched-Pair Analysis. J Arthroplasty. 2017. PMID: 29157785. doi:10.1016/j.arth.2017.10.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。